XML 12 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 19,735,943 $ 23,693,633
Short-term investments 86,235,815 57,538,852
Accounts receivable 130,230 3,316,361
Accounts receivable from affiliated entities 996,936 738,583
Prepaid expenses and other current assets 2,309,362 1,406,590
Prepaid expenses and other current assets from affiliated entities 1,100,746 1,120,805
Total current assets 110,509,032 87,814,824
Fixed assets, net 14,265,951 15,949,014
Investment in affiliated entity - GeneOne 6,324,766 6,381,926
Investment in affiliated entity - PLS 2,157,832 3,023,987
Intangible assets, net 4,227,019 4,760,145
Goodwill 10,513,371 10,513,371
Operating lease right-of-use assets 14,222,236  
Other assets 2,853,089 2,669,998
Total assets 165,073,296 131,113,265
Current liabilities:    
Accounts payable and accrued expenses 13,388,013 23,134,733
Accounts payable and accrued expenses due to affiliated entities 653,568 977,792
Accrued clinical trial expenses 4,638,397 5,671,764
Deferred revenue 120,694 223,577
Deferred revenue from affiliated entities 96,075 33,575
Deferred rent   1,065,387
Operating lease liability 1,948,716  
Deferred grant funding 2,470,657 4,165,848
Deferred grant funding from affiliated entities 763,208 27,083
Total current liabilities 24,079,328 35,299,759
Deferred revenue, net of current portion 116,630 150,793
Convertible senior notes 62,757,286 0
Deferred rent, net of current portion   8,518,207
Operating lease liability, net of current portion 21,483,568  
Deferred tax liabilities 26,649 24,766
Deferred grant funding from affiliated entities 81,000 0
Other liabilities 50,762 87,333
Total liabilities 108,595,223 44,080,858
Stockholders’ equity:    
Preferred stock 0 0
Common stock 98,584 97,226
Additional paid-in capital 731,819,389 707,794,215
Accumulated deficit (679,032,924) (620,426,436)
Accumulated other comprehensive income (loss) 731,855 (528,867)
Total Inovio Pharmaceuticals, Inc. stockholders’ equity 53,616,904 86,936,138
Non-controlling interest 2,861,169 96,269
Total stockholders’ equity 56,478,073 87,032,407
Total liabilities and stockholders’ equity $ 165,073,296 $ 131,113,265